Invesco Global Health Care B
Name
As ofPrice
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
N/A
1 yr return
14.6%
3 Yr Avg Return
0.9%
5 Yr Avg Return
11.6%
Net Assets
$1.42 B
Holdings in Top 10
35.1%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.87%
SALES FEES
Front Load N/A
Deferred Load 5.00%
TRADING FEES
Turnover 36.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$250
Fund Classification
Fund Type
Open End Mutual Fund
Name
As ofPrice
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
GTHBX - Profile
Distributions
- YTD Total Return N/A
- 3 Yr Annualized Total Return 0.1%
- 5 Yr Annualized Total Return 11.4%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.87%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameInvesco Global Health Care Fund
-
Fund Family NameInvesco
-
Inception DateApr 01, 1993
-
Shares OutstandingN/A
-
Share ClassB
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerHenry Wu
Fund Description
GTHBX - Performance
Return Ranking - Trailing
Period | GTHBX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -3.0% | 33.2% | N/A |
1 Yr | 14.6% | -24.9% | 12.0% | N/A |
3 Yr | 0.9%* | -17.8% | 22.2% | N/A |
5 Yr | 11.6%* | -11.9% | 16.9% | N/A |
10 Yr | 7.2%* | -1.8% | 16.1% | N/A |
* Annualized
Return Ranking - Calendar
Period | GTHBX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -25.3% | 7.7% | N/A |
2022 | N/A | -10.8% | 43.9% | N/A |
2021 | N/A | -29.8% | 2.6% | N/A |
2020 | N/A | -20.4% | 13.8% | N/A |
2019 | N/A | -5.8% | 31.5% | N/A |
Total Return Ranking - Trailing
Period | GTHBX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -3.0% | 33.2% | N/A |
1 Yr | 9.6% | -24.9% | 12.0% | N/A |
3 Yr | 0.1%* | -17.8% | 25.3% | N/A |
5 Yr | 11.4%* | -11.9% | 18.8% | N/A |
10 Yr | 7.2%* | -1.8% | 19.4% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | GTHBX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -25.3% | 12.3% | N/A |
2022 | N/A | -10.8% | 45.8% | N/A |
2021 | N/A | -24.2% | 8.7% | N/A |
2020 | N/A | -16.6% | 15.2% | N/A |
2019 | N/A | -5.8% | 36.7% | N/A |
GTHBX - Holdings
Concentration Analysis
GTHBX | Category Low | Category High | GTHBX % Rank | |
---|---|---|---|---|
Net Assets | 1.42 B | 13.9 M | 44.3 B | N/A |
Number of Holdings | 75 | 28 | 364 | N/A |
Net Assets in Top 10 | 485 M | 7.98 M | 18.8 B | N/A |
Weighting of Top 10 | 35.12% | 24.8% | 75.2% | N/A |
Top 10 Holdings
- Celgene Corp 4.98%
- Thermo Fisher Scientific Inc 4.28%
- Novartis AG ADR 4.18%
- UnitedHealth Group Inc 3.96%
- Bristol-Myers Squibb Company 3.43%
- Zimmer Biomet Holdings Inc 3.17%
- Eli Lilly and Co 3.13%
- Shire PLC ADR 2.72%
- Alexion Pharmaceuticals Inc 2.63%
- Biomarin Pharmaceutical Inc 2.63%
Asset Allocation
Weighting | Return Low | Return High | GTHBX % Rank | |
---|---|---|---|---|
Stocks | 94.86% | 91.85% | 103.82% | N/A |
Cash | 5.14% | 0.00% | 5.75% | N/A |
Preferred Stocks | 0.00% | 0.00% | 2.32% | N/A |
Other | 0.00% | -3.83% | 2.75% | N/A |
Convertible Bonds | 0.00% | 0.00% | 0.12% | N/A |
Bonds | 0.00% | 0.00% | 0.94% | N/A |
Stock Sector Breakdown
Weighting | Return Low | Return High | GTHBX % Rank | |
---|---|---|---|---|
Healthcare | 92.47% | 13.80% | 99.56% | N/A |
Industrials | 1.18% | 0.00% | 10.61% | N/A |
Consumer Defense | 0.66% | 0.00% | 0.40% | N/A |
Technology | 0.56% | 0.00% | 61.10% | N/A |
Utilities | 0.00% | 0.00% | 0.00% | N/A |
Real Estate | 0.00% | 0.00% | 1.36% | N/A |
Financial Services | 0.00% | 0.00% | 3.95% | N/A |
Energy | 0.00% | 0.00% | 0.09% | N/A |
Communication Services | 0.00% | 0.00% | 0.00% | N/A |
Consumer Cyclical | 0.00% | 0.00% | 7.87% | N/A |
Basic Materials | 0.00% | 0.00% | 0.79% | N/A |
Stock Geographic Breakdown
Weighting | Return Low | Return High | GTHBX % Rank | |
---|---|---|---|---|
US | 78.36% | 60.46% | 99.56% | N/A |
Non US | 16.50% | 0.00% | 39.02% | N/A |
GTHBX - Expenses
Operational Fees
GTHBX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.87% | 0.10% | 2.98% | N/A |
Management Fee | 0.62% | 0.09% | 1.25% | N/A |
12b-1 Fee | 1.00% | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.01% | 0.40% | N/A |
Sales Fees
GTHBX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 2.50% | 5.75% | N/A |
Deferred Load | 5.00% | 1.00% | 5.00% | N/A |
Trading Fees
GTHBX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 0.75% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
GTHBX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 36.00% | 0.00% | 699.00% | N/A |
GTHBX - Distributions
Dividend Yield Analysis
GTHBX | Category Low | Category High | GTHBX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 0.01% | N/A |
Dividend Distribution Analysis
GTHBX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Annually | Annually |
Net Income Ratio Analysis
GTHBX | Category Low | Category High | GTHBX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.87% | -2.15% | 1.48% | N/A |
Capital Gain Distribution Analysis
GTHBX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
GTHBX - Fund Manager Analysis
Managers
Henry Wu
Start Date
Tenure
Tenure Rank
Feb 28, 2017
0.92
0.9%
Henry Wu, Portfolio Manager, has been associated with Invesco and/or its affiliates since 2014 (and was previously associated with Invesco and/or its affiliates from 2006 to 2010). From 2012 to 2013, he was employed by Scopia Capital as a senior analyst. From 2010 to 2012, he was employed by Surveyor Capital/Citdadel Investment Group as an analyst.
Derek Taner
Start Date
Tenure
Tenure Rank
Apr 29, 2005
12.77
12.8%
Derek Taner is the lead portfolio manger for the Invesco Global Health Care team. Mr. Taner joined Invesco in 2005, coming from Franklin Advisers Inc. where he served as a portfolio manager on Franklin Templeton’s health care team from 2002 through 2005 — the fi nal two years as lead manager. He began his investment career in 1993 as a fi xed-income analyst with Franklin Templeton and was promoted to assistant portfolio manager in 1997. In 2000, he joined the fi rm’s equity department and was named co-manager of its equity-income product. Mr. Taner earned a Bachelor of Science degree in business administration with an emphasis in accounting and fi nance and a Master of Business Administration degree from the Haas School of Business at the University of California (Berkeley). He is a CFA charterholder.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
4.38 | 13.75 | 9.07 | 4.38 |